1. 4CPS-107 An estimate of avoided costs for drugs in patients included in non-small lung cancer clinical trials. (2nd March 2018) Authors: Alamo, AM; Mateos, E; Nucete, B; Lujan, ME; Lombardero, M; Otero, C Journal: European journal of hospital pharmacy Issue: Volume 25(2018)Supplement 1 Page Start: A91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 5PSQ-041 Incidents due to the use of antibiotics detected in the paediatric emergency service of a third-level hospital. (2nd March 2018) Authors: Otero, C; Hernández, Y; Garrido, B; Dolz, E; Hernandez, A; Majuelos, L; Fernandez, D; Lombardero, M; Velaz, A Journal: European journal of hospital pharmacy Issue: Volume 25(2018)Supplement 1 Page Start: A183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 5PSQ-049 Atezolizumab: efficacy and safety in advanced non-small cell lung cancer. (March 2019) Authors: Fernandez, D; Otero, C; Álamo, A; Mateos, E; Lombardero, M; Lujan, ME; Dorta, D; Dominguez, A Journal: European journal of hospital pharmacy Issue: Volume 26(2019)Supplement 1 Page Start: A224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Gastroenterology: Revisiting the forgotten sign: Five layered gut signature and Y configuration in enteric duplication cysts on high resolution ultrasound. Issue 7 (July 2015) Authors: Kumar, D; Ramanathan, S; Haider, E; Khanna, M; Otero, C Journal: Journal of gastroenterology and hepatology Issue: Volume 30:Issue 7(2015:Jul.) Page Start: 1111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗